Radiation therapy can boost longevity in rare pancreatic cancer patients
People with rare pancreatic cancer, called pancreatic neuroendocrine tumours (PNTs), might live longer if treated with radiation therapy, says a study.
The researchers found that this method is effective in achieving local control and palliation in PNTs, despite such tumours being commonly considered resistant to radiation therapy.
PNT is a very rare form of pancreatic cancer that can stay confined to the liver and often cause death from liver damage.
As it is usually unable to be removed by surgery, external beam radiation therapy (EBRT) is an attractive option for managing the disease.
However, the role of EBRT is largely unknown because of the low incidence of this tumour type and, as a result, very few related studies.
Researchers at the departments of radiation oncology and internal medicine, division of hematology/oncology and comprehensive cancer center biostatistics unit at the University of Michigan in Ann Arbor, Mich., wanted to determine if PNTs are not as resistant to radiation therapy as was previously thought.
Thus, they reviewed records from 36 patients with PNTs who were treated between 1986 and 2006 with radiation therapy to 49 sites.
And the researchers found that in 39 percent of patients the tumour shrunk to less than half its pretreatment size after being treated with EBRT.
Also, radiation therapy treatments achieved high rates of local control and 90 percent of patients experienced palliation of symptoms such as pain, nausea, vomiting or obstructive jaundice.
“While this particular type of cancer can have potentially devastating effects on a patient, this study proves that using external beam radiation therapy may permit these patients to live longer, which is a very positive breakthrough for a disease that can have very negative outcomes,” said Dr. Theodore S. Lawrence, an author on the study.
The study is published in the latest issue of the International Journal of Radiation Oncology. (ANI)
Go to Source
People who read this also read
- Christie patients receive revolutionary cancer treatment for first time
For the first time ever, patients at The Christie are benefitting from a revolutionary radiotherapy treatment which dramatically cuts treatment time, whilst better targeting the tumour.
The Christi... - Gene Target For Cancer Therapy
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, gained international validation of the cutting-edge science behind its lead oncology product, Rexin-G,... - Cetuximab with chemo shrinks more secondaries
Liver metastases surgery more likely after cetuximab added to chemotherapyRelated items from OnMedicaSurgery after radiation therapy effective for rectal cancerCancer survival rates not improved much ... - Rare Pancreatic Cancer Patients May Live Longer When Treated With Radiation Therapy
Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation ... - Most radiation oncologists utilize advanced medical imaging techniques, study suggests
(American College of Radiology / American Roentgen Ray Society) A recent study shows that 95 percent of radiation oncologists use advanced imaging techniques such as positron emission tomography, magn... - Roseville Radiation Oncology Center (ROC) Redefines Efficiency With Elekta VMAT Radiotherapy Treatments
The first treatments with Elekta Volumetric Modulated Arc Therapy (VMAT) began November 17, 2009 at Roseville Radiation Oncology Center (ROC) at Radiological Associates of Sacramento (RAS). RAS, a lar... - National Imaging Associates Applauds FDA Initiative To Reduce Unnecessary Radiation Exposure From Medical Imaging
National Imaging Associates (NIA), a Magellan Health Services (Nasdaq:MGLN) company, today applauded the U.S. Food and Drug Administration (FDA) for its leadership and progress in addressing the issue... - Robotic Assisted Laparoscopic Salvage Prostatectomy For Radiation Resistant Prostate Cancer
UroToday.com - Salvage radical prostatectomy for prostate cancer (CaP) recurrence after radiotherapy (XRT) has improved over time but complications, especially incontinence, remain high. In the Janua... - ALDH Associated With Worse Overall Survival In Patients With Pancreatic Adenocarcinoma
Expression of aldehyde dehydrogenase (ALDH) in pancreatic adenocarcinoma is associated with worse overall survival in patients who have undergone resection for early-stage disease, according to a new ... - Discovery Of Biomarkers In Saliva For Detection Of Early-Stage Pancreatic Cancer
Physicians and scientists agree: If we cannot entirely prevent cancer, the next best thing is to find it earlier to augment the chances of a successful fight. The good news is that there may soon be...
